Garo H. Armen - 16 Jan 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
/s/ Christine Klaskin, Attorney-in-Fact for Garo H. Armen
Issuer symbol
INKT
Transactions as of
16 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 11:34:44 UTC
Previous filing
09 Jan 2023
Next filing
04 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INKT Stock Option Award $0 +200,000 $0.000000 200,000 16 Jan 2023 Common Stock 200,000 $2.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase Common Stock was awarded to Dr. Armen for his service as MiNK Therapeutic Inc.'s Chairman of the Board. The option was granted on January 16, 2023 and was awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option will vest on January 16, 2024.